Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
Express Scripts
McKinsey
McKesson

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Ingenus Pharms Llc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INGENUS PHARMS LLC, and what generic alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has eleven approved drugs.

There is one US patent protecting INGENUS PHARMS LLC drugs.

There is one patent family member on INGENUS PHARMS LLC drugs in one country and fifteen supplementary protection certificates in eight countries.

Summary for Ingenus Pharms Llc
International Patents:1
US Patents:1
Tradenames:11
Ingredients:11
NDAs:11

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 210947-001 Feb 18, 2020 AP RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Ingenus Pharms Llc METAXALONE metaxalone TABLET;ORAL 213836-001 Oct 21, 2020 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Ingenus Pharms Llc PALONOSETRON HYDROCHLORIDE palonosetron hydrochloride INJECTABLE;INTRAVENOUS 208789-001 May 22, 2020 AP RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Ingenus Pharms Llc ARSENIC TRIOXIDE arsenic trioxide INJECTABLE;INJECTION 209315-002 Jan 14, 2021 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Ingenus Pharms Llc CYCLOPHOSPHAMIDE cyclophosphamide SOLUTION;INTRAVENOUS 212501-002 Jul 30, 2020 RX Yes Yes 10,993,952 ⤷  Sign up for a Free Trial Y ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Ingenus Pharms Llc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0430190 18/2005 Austria ⤷  Sign up for a Free Trial PRODUCT NAME: PALONOSETRON, DESSEN SALZE UND STEREOISOMERE; REGISTRATION NO/DATE: EU/1/04/306/001 20050322
1667986 92172 Luxembourg ⤷  Sign up for a Free Trial PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
0258618 SPC/GB01/042 United Kingdom ⤷  Sign up for a Free Trial PRODUCT NAME: ZOLEDRONIC ACID 2-(IMIDAZOL-1-YL)-1-HYDROXYETHANE-1,1-DIPHOSPHONIC ACID; REGISTERED: CH 55463 20001128; UK EU/1/01/176/001 20010320; UK EU/1/01/176/002 20010320; UK EU/1/01/176/003 20010320
1667986 28/2013 Austria ⤷  Sign up for a Free Trial PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317
0275821 01C0035 France ⤷  Sign up for a Free Trial PRODUCT NAME: ZOLEDRONIC ACID; NAT REG. NO/DATE: EU/1/01/176/001 20010320; FIRST REG.: LI IKS N 55 463 20001128
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
McKesson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.